Ryman Healthcare Ltd
NZX:RYM
Intrinsic Value
Ryman Healthcare Ltd. engages in the development and management of integrated retirement villages for the elderly. [ Read More ]
The intrinsic value of one
RYM
stock under the Base Case scenario is
10.88
NZD.
Compared to the current market price of 4.26 NZD,
Ryman Healthcare Ltd
is
Undervalued by 61%.
Ryman Healthcare Ltd's market capitalization is 2.9B NZD.
RYM stock price is 4.26 NZD.
RYM stock price (4.26 NZD) is 61% less than its Intrinsic Value (10.88 NZD).
RYM has upside potential of 65% compared to the average analyst price target.
Open Wall St Estimates
RYM's ROIC (Return on Invested Capital) has decreased in the last 3 years from 0% to 0%.
RYM's ROE (Return on Equity) for the past 12 months is positive and is equal to 6%.
RYM's Revenue has grown by 16% over the past 12 months.
RYM has positive three-year average ROE (Return on Equity): 14%. The company is efficient at transforming stockholders' equity into net income.
RYM's ROIC (Return on Invested Capital) for the past 12 months is very low and is equal to 0%.
RYM's Revenue has been growing by 12% per year for the last 3 years.
RYM's ROE (Return on Equity) has significantly decreased in the last 3 years from 16% to 6%.
RYM has positive Operating Income for the last twelve months.
RYM's long-term assets (13B NZD) exceed its long-term liabilties (8B NZD).
RYM's Revenue is forecast to grow at a rate of 21% per year over the next 3 years.
RYM has a very low three-year average ROIC (Return on Invested Capital): 0%. The company is not efficient at using invested capital to generate operating income.
RYM has positive Net Income for the last twelve months.
RYM's D/E (Debt to Equity) is very low and is equal to 0.52.
RYM has positive Free Cash Flow for the last twelve months.
RYM's short-term liabilties (6B NZD) exceed its short-term assets (803m NZD).
RYM has positive Net Debt. This means that the company has more debt (3B NZD) than cash and short-term investments (33m NZD).
RYM's Altman Z-Score is very low and is equal to 0.28.
RYM doesn't generate enough operating income (9m NZD) to safely cover interest payments on its debt (-51m NZD).
Valuation Backtest
Ryman Healthcare Ltd
Run backtest to discover the historical profit from buying and selling
RYM
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Ryman Healthcare Ltd
Balance Sheet Decomposition
Ryman Healthcare Ltd
| Current Assets | 803m |
| Cash & Short-Term Investments | 33.3m |
| Receivables | 677.7m |
| Other Current Assets | 92m |
| Non-Current Assets | 12.3B |
| Long-Term Investments | 9.8B |
| PP&E | 2.2B |
| Intangibles | 85.7m |
| Other Non-Current Assets | 125.7m |
| Current Liabilities | 5.6B |
| Accounts Payable | 146.1m |
| Accrued Liabilities | 55.2m |
| Other Current Liabilities | 5.4B |
| Non-Current Liabilities | 2.6B |
| Long-Term Debt | 2.5B |
| Other Non-Current Liabilities | 125.8m |
Earnings Waterfall
Ryman Healthcare Ltd
|
Revenue
|
619.7m
NZD
|
|
Operating Expenses
|
-610.8m
NZD
|
|
Operating Income
|
8.9m
NZD
|
|
Other Expenses
|
241.6m
NZD
|
|
Net Income
|
250.5m
NZD
|
Free Cash Flow Analysis
Ryman Healthcare Ltd
RYM Profitability Score
Profitability Due Diligence
Ryman Healthcare Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
Score
Ryman Healthcare Ltd's profitability score is 55/100. The higher the profitability score, the more profitable the company is.
RYM Solvency Score
Solvency Due Diligence
Ryman Healthcare Ltd's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Score
Ryman Healthcare Ltd's solvency score is 21/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
RYM Price Targets Summary
Ryman Healthcare Ltd
According to Wall Street analysts, the average 1-year price target for
RYM
is 7.02 NZD
with a low forecast of 5.34 NZD and a high forecast of 8.66 NZD.
Shareholder Return
RYM Price
Ryman Healthcare Ltd
| Average Annual Return | -8.85% |
| Standard Deviation of Annual Returns | 41.55% |
| Max Drawdown | -74% |
| Market Capitalization | 2.9B NZD |
| Shares Outstanding | 685 147 456 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Ryman Healthcare Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Ryman Healthcare Ltd. engages in the development and management of integrated retirement villages for the elderly. The firm offers various living and care options, including independent living, assisted living, resthome, hospital and dementia. The independent townhouses and apartments are occupied by residents wishing to retain a level of independence. The firm's Assisted Living offers a range of services, including meals, housekeeping services, morning and afternoon tea, shopping trips and the resort style facilities offered by the village. Resthome and Hospital level care in its Village offers residents in clinical care. The firm offers a specialized care unit for residents. The firm's Villages include residents requiring short-term care, respite care and day care. The firm also offers Day Care program for those just needing assistance during the day. The firm operates in New Zealand with various operations in Australia.
Contact
IPO
Employees
Officers
The intrinsic value of one
RYM
stock under the Base Case scenario is
10.88
NZD.
Compared to the current market price of 4.26 NZD,
Ryman Healthcare Ltd
is
Undervalued by 61%.
You don't have any saved screeners yet
